Pharma Nutria

Pharma Nutria N.A., Inc. is a prominent pharmaceutical marketing and distribution company based in the Philippines and a key parent entity within the S.V. More Group of Companies. Established in 1995, the company specializes in the commercialization of a diverse portfolio of healthcare products, including its flagship high-dose B-complex vitamins (Polynerv) and gastrointestinal treatments (Gastrec). Pharma Nutria operates through an extensive nationwide distribution network and maintains strategic partnerships with international pharmaceutical innovators from South Korea, Australia, and Europe to license and distribute novel therapies. Notably, the company acts as a strategic investor in the life sciences sector, recently increasing its equity stake in the Australian biotech firm Firebrick Pharma to support the development of Nasodine nasal spray. Its business model integrates scientific marketing with a robust supply chain to provide high-quality, cost-effective medical solutions across the Philippines.